| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/05/1999 | WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 08/05/1999 | CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318830A1 Derivatives of 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/04/1999 | EP0932410A1 Mistletoe (viscum) extracts |
| 08/04/1999 | EP0932406A1 Methods of treating or preventing interstitial cystitis |
| 08/04/1999 | EP0695309B1 Oxytocin antagonist |
| 08/04/1999 | EP0575490B1 GnRH ANALOGS |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1224720A Tetracylic derivatives, process of preparation and use |
| 08/04/1999 | CN1224718A Thiazole derivatives |
| 08/03/1999 | US5932765 Nitromethyl ketones, process for preparing them and compositions containing them |
| 08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
| 08/03/1999 | US5932730 Endothelin antagonist |
| 08/03/1999 | US5932607 Imidazole derivatives and process for preparing the same |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932593 Antiserotonin agent |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions |
| 08/03/1999 | US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
| 08/03/1999 | CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 07/29/1999 | WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/29/1999 | WO1999037637A1 Benzamide derivatives as vasopressin antagonists |
| 07/29/1999 | WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/29/1999 | WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2319113A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/28/1999 | EP0931145A1 Ptx sensitive g proteins, the production and use thereof |
| 07/28/1999 | EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0930891A1 Oral administration of chicken yolk antibodies to treat disease |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | CN1224356A Non-aqueous protic peptide formulations |
| 07/27/1999 | US5929249 Angiotensin ii receptor antagonists |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5929028 Liquid gonadotropin containing formulations |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999025690A3 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929218A2 P2y receptor antagonists |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223643A Prenyl transferase inhibitors |
| 07/21/1999 | CN1223136A Quick-acting preparation for litholysis |
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/21/1999 | CN1044234C Substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |
| 07/14/1999 | EP0928788A1 Imidazolidin-4-one derivatives useful as anticancer agents |
| 07/14/1999 | EP0665833B1 Dopamine receptor subtype ligands |
| 07/14/1999 | CN1222381A Medicine liquid for discharge of stone |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | CA1340653C Method for improving reproductive functions in mammals |
| 07/13/1999 | CA1340649C Purified follicle stimulating hormone |
| 07/08/1999 | WO1999033849A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033828A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | WO1999033460A1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 07/08/1999 | WO1999033454A2 S-procyclidine for treating urinary incontinence |
| 07/08/1999 | WO1999033453A2 R-procyclidine for treating urinary incontinence |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | CA2316385A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | CA2316352A1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 07/08/1999 | CA2315843A1 S-procyclidine for treating urinary incontinence |
| 07/08/1999 | CA2315840A1 R-procyclidine for treating urinary incontinence |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | CA2315055A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927150A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/07/1999 | EP0927034A1 Method of treating urinary incontinence |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/07/1999 | CN1221617A Prescription capsule for removing kidney stone |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919775 Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | CA2004764C Ancrod proteins, their preparation and use |
| 07/01/1999 | WO1999032510A1 Kappa receptor opioid peptides |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |